| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
7e-05 |
| mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0001 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0001 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
| mRNA |
CGP-60474 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
0.0008 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |